- Home
- MAT vs FOLD Comparison
MAT vs FOLD Comparison
Compare MAT & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAT | FOLD |
|---|---|---|
| Founded | 1945 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.5B |
| IPO Year | 1994 | 2006 |
Fundamental Metrics
Financial Performance| Metric | MAT | FOLD |
|---|---|---|
| Price | $16.20 | $14.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | $21.11 | ★ $27.25 |
| AVG Volume (30 Days) | ★ 7.9M | 3.3M |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.00 |
| EPS | ★ 1.24 | N/A |
| Revenue | ★ $5,347,623,000.00 | N/A |
| Revenue This Year | $5.99 | $20.50 |
| Revenue Next Year | $5.05 | $18.59 |
| P/E Ratio | $12.93 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.95 | $5.66 |
| 52 Week High | $22.48 | $14.38 |
Technical Indicators
Market Signals| Indicator | MAT | FOLD |
|---|---|---|
| Relative Strength Index (RSI) | 34.77 | 69.47 |
| Support Level | $14.75 | $14.21 |
| Resistance Level | $19.33 | N/A |
| Average True Range (ATR) | 0.52 | 0.03 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 27.27 | 78.57 |
Price Performance
Historical ComparisonAbout MAT Mattel Inc.
Mattel manufactures and markets toy products that are sold to its wholesale partners and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2025, with the remainder stemming from international markets.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.